Did you know that antibody-drug conjugates (ADCs) are powerful therapies against HER2-positive cancers? These potent targeted treatments combine ..read more

With Labcorp’s first-trimester screening and late-trimester risk evaluation tests, you can detect #preeclampsia risks before they escalate and help ..read more

Meet our leaders and specialists at booth 1341 to learn how you can optimize your clinical trials with powerful data-driven solutions. Join the site ..read more

Thank you to those around the globe who place their trust in us every day. Each one of you play an integral role in our mission to improve health and ..read more

The Labcorp Charitable Foundation was proud to support Novant Health Foundation and their partnership with Nourish Up in the fight against food ..read more

Labcorp will be attending multiple university and college campuses during the spring recruiting season. We have many #internship opportunities for ..read more

Introduction and U.K.’s exit from the EU On leaving the EU, EU-REACH legislation was copied over into UK-REACH as of 01 January 2020. Applying to only England, Wales and Scotland (collectively referred to as Great Britain or GB), Northern Ireland continues to be regulated by EU-REACH. The UK-REACH transitional arrangements … The post UK-REACH Planning appeared first on Insights From Our Labs to Yours ..read more

When it comes to designing clinical trials with expedience and efficiency, many drug developers are choosing biomarker-driven strategies for their investigational precision medicines. As key features of developing new therapies and diagnostics, biomarkers define the disease biology, provide potential targets for new therapies and provide strong potential for market differentiation. … The post Top considerations for developing a biomarker solution and CDx strategy appeared first on Insights From Our Labs to Yours ..read more

The European Chemicals Agency (ECHA) recently conducted a review project regarding the design of the OECD 443 (Extended One-Generation Reproductive Toxicity Study, or EOGRTS). The project’s goal was to assess the performance of the study in terms of study design, conduct and findings to determine if the study design currently … The post How to de-risk OECD 443 studies through optimized dose level selections appeared first on Insights From Our Labs to Yours ..read more

Every clinical trial relies on data from its study participants to inform decisions regarding the safety and efficacy of a potential new treatment. Clinical trial sponsors rely on the data from laboratory tests to bring clear insights that advance studies. Labcorp Central Laboratory Services generates more clinical trial data than … The post What does a central lab do? 4 core services to know appeared first on Insights From Our Labs to Yours ..read more